Home · Healthcare M&A · Medical Practice Valuation Calculator
Free Tool · 2026 NJ/NY Multiples
A working-broker's estimate of what your NJ or NY medical or dental practice might sell for in 2026. Inputs: specialty, normalized EBITDA, ASC ownership status, payer mix, and group size. Output: estimated valuation range based on real 2026 PE-platform transaction multiples. Free, no signup required, no obligation.
Estimates based on Nexus Bridge's analysis of 2026 NJ/NY PE-platform and strategic healthcare M&A transactions. Real-world valuations depend on factors not captured in this calculator: specific buyer interest, deal structure, rollover equity terms, real estate, regulatory complexity, and competitive auction dynamics. This calculator provides a working estimate; for a defensible valuation specific to your practice, request a free confidential evaluation.
The calculator uses 2026 transaction-data multiples for each specialty, then applies adjustments based on the factors that meaningfully change valuations:
Pick Dental (general) or Dental (specialty — ortho/perio/endo) in the specialty list and enter normalized EBITDA. The calculator applies the 2026 bands we publish on our New Jersey dental practice page: roughly 4×–6× EBITDA for a general practice that a DSO or group would buy, and 5×–7× for an orthodontic, periodontal or endodontic practice. Then run the second test dentists actually get priced on: a doctor-to-doctor sale of a general practice in NJ typically lands at 65%–85% of trailing-twelve-month collections. If the EBITDA figure and the collections figure disagree by more than about 20%, the gap is almost always one of three things — hygiene production that is being counted as doctor production, PPO write-offs that have not been normalized, or an owner salary add-back that a DSO will not accept. Leave ASC ownership at “none” for a dental practice; the payer-mix and group-size adjustments still apply. The result is a range to take into a conversation, not an appraisal — and a DSO offer has to be broken into cash at close, earnout, rollover equity and post-close employment before it can be compared with a doctor buyer’s number.
Real-world healthcare valuations vary based on factors this calculator can't capture:
A confidential valuation, free, with no obligation and no upfront fee. We will tell you what your business is likely to fetch in today’s NJ/NY practice market, what is holding the number down, and what is worth fixing before you go anywhere near a buyer. If the answer is “not yet,” we will tell you that too.
For an evidence-based valuation specific to your practice — including comparable transaction analysis, PE-buyer fit assessment, and rollover-equity scenarios — schedule a free confidential 30-minute conversation. No obligation. No upfront fees. Delivered in writing within 7 days.
Related: Healthcare M&A NJ Guide · Healthcare M&A Glossary · Quality of Earnings Guide · Sell an ASC

Boutique business brokerage for owners across New Jersey, New York, NYC & Connecticut. $0 upfront. Success-based fee only.